Targeting of autoantigens to DEC205+ dendritic cells in vivo suppresses experimental allergic encephalomyelitis in mice

Journal of Immunology

Volumn 191, Issue 6, 2013, Pages 2938-2947

  Ring, Sabine ^a   Maas, Michael ^a   Nettelbeck, Dirk M ^a,b   Enk, Alexander H ^a   Mahnke, Karsten ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; B7 ANTIGEN; BETA GALACTOSIDASE; CD40 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCOPROTEIN P 15095; HYBRID PROTEIN; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FLOW CYTOMETRY; IMMUNOMODULATION; IMMUNOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITHELIAL CELLS; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; RECEPTORS, CELL SURFACE;

EID: 84884216197     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202592     Document Type: Article

References (41)

1. Steinman, R. M. 2012. Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 30: 1-22.
2. Mahnke, K., J. Knop, and A. H. Enk. 2003. Induction of tolerogenic DCs: 'you are what you eat'. Trends Immunol. 24: 646-651.
3. Mahnke, K., T. S. Johnson, S. Ring, and A. H. Enk. 2007. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. J. Dermatol. Sci. 46: 159-167.
4. Jonuleit, H., E. Schmitt, K. Steinbrink, and A. H. Enk. 2001. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22: 394-400.
5. Bonifaz, L., D. Bonnyay, K. Mahnke, M. Rivera, M. C. Nussenzweig, and R. M. Steinman. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196: 1627-1638.
6. Hawiger,D., K. Inaba, Y.Dorsett,M. Guo,K.Mahnke,M. Rivera, J. V.Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779.
7. Mahnke, K., Y. Qian, J. Knop, and A. H. Enk. 2003. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101: 4862-4869.
8. Constantinescu, C. S., N. Farooqi, K. O'Brien, and B. Gran. 2011. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 164: 1079-1106.
9. Stromnes, I. M., and J. M. Goverman. 2006. Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 1: 1810-1819.
10. Johnson, T. S., K. Mahnke, V. Storn, K. Schönfeld, S. Ring, D. M. Nettelbeck, H. J. Haisma, F. Le Gall, R. E. Kontermann, and A. H. Enk. 2008. Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule. Clin. Cancer Res. 14: 8169-8177.
11. Mahnke, K., M. Guo, S. Lee, H. Sepulveda, S. L. Swain, M. C. Nussenzweig, and R. M. Steinman. 2000. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151: 673-684.
12. Mahnke, K., E. Schmitt, L. Bonifaz, A. H. Enk, and H. Jonuleit. 2002. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 80: 477-483.
13. Ring, S., A. H. Enk, and K. Mahnke. 2010. ATP activates regulatory T cells in vivo during contact hypersensitivity reactions. J. Immunol. 184: 3408-3416.
14. Inaba, K., S. Turley, T. Iyoda, F. Yamaide, S. Shimoyama, C. Reis e Sousa, R. N. Germain, I. Mellman, and R. M. Steinman. 2000. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191: 927-936.
15. Idoyaga, J., A. Lubkin, C. Fiorese, M. H. Lahoud, I. Caminschi, Y. Huang, A. Rodriguez, B. E. Clausen, C. G. Park, C. Trumpfheller, and R. M. Steinman. 2011. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc. Natl. Acad. Sci. USA 108: 2384-2389.
16. Idoyaga, J., C. Cheong, K. Suda, N. Suda, J. Y. Kim, H. Lee, C. G. Park, and R. M. Steinman. 2008. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J. Immunol. 180: 3647-3650.
17. Klechevsky, E., A. L. Flamar, Y. Cao, J. P. Blanck, M. Liu, A. O'Bar, O. Agouna-Deciat, P. Klucar, L. Thompson-Snipes, S. Zurawski, et al. 2010. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Blood 116: 1685-1697.
18. Mahnke, K., Y. Qian, S. Fondel, J. Brueck, C. Becker, and A. H. Enk. 2005. Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice. Cancer Res. 65: 7007-7012.
19. Cheong, C., J. H. Choi, L. Vitale, L. Z. He, C. Trumpfheller, L. Bozzacco, Y. Do, G. Nchinda, S. H. Park, D. B. Dandamudi, et al. 2010. Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody. Blood 116: 3828-3838.
20. Shimizu, K., Y. Kurosawa, M. Taniguchi, R.M. Steinman, and S. Fujii. 2007. Crosspresentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J. Exp. Med. 204: 2641-2653.
21. Charalambous, A., M. Oks, G. Nchinda, S. Yamazaki, and R. M. Steinman. 2006. Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin. J. Immunol. 177: 8410-8421.
22. Wang, B., N. Zaidi, L. Z. He, L. Zhang, J. M. Kuroiwa, T. Keler, and R. M. Steinman. 2012. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice. Breast Cancer Res. 14: R39.
23. Bruder, D., A. M. Westendorf, W. Hansen, S. Prettin, A. D. Gruber, Y. Qian, H. von Boehmer, K. Mahnke, and J. Buer. 2005. On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 54: 3395-3401.
24. Mukhopadhaya, A., T. Hanafusa, I. Jarchum, Y. G. Chen, Y. Iwai, D. V. Serreze, R. M. Steinman, K. V. Tarbell, and T. P. DiLorenzo. 2008. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Proc. Natl. Acad. Sci. USA 105: 6374-6379.
25. Luo, X., K. V. Tarbell, H. Yang, K. Pothoven, S. L. Bailey, R. Ding, R. M. Steinman, and M. Suthanthiran. 2007. Dendritic cells with TGF-beta1 differentiate naive CD4+CD25-T cells into islet-protective Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 104: 2821-2826.
26. Yamazaki, S., A. J. Bonito, R. Spisek,M. Dhodapkar, K. Inaba, and R. M. Steinman. 2007. Dendritic cells are specialized accessory cells along with TGF-for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors. Blood 110: 4293-4302.
27. Liu, G., K. Duan, H. Ma, Z. Niu, J. Peng, and Y. Zhao. 2011. An instructive role of donor macrophages in mixed chimeras in the induction of recipient CD4(+) Foxp3(+) Treg cells. Immunol. Cell Biol. 89: 827-835.
28. Bettelli, E., M. P. Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10-and IL-4-deficient and transgenic mice. J. Immunol. 161: 3299-3306.
29. Rynda-Apple, A., E. Huarte, M. Maddaloni, G. Callis, J. A. Skyberg, and D. W. Pascual. 2011. Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells. Eur. J. Immunol. 41: 313-323.
30. Mahnke, K., S. Ring, T. S. Johnson, S. Schallenberg, K. Schönfeld, V. Storn, T. Bedke, and A. H. Enk. 2007. Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation. Eur. J. Immunol. 37: 2117-2126.
31. Müller, G., A. Müller, T. Tüting, K. Steinbrink, J. Saloga, C. Szalma, J. Knop, and A. H. Enk. 2002. Interleukin-10-treated dendritic cells modulate immune responses of naive and sensitized T cells in vivo. J. Invest. Dermatol. 119: 836-841.
32. Liu, K., T. Iyoda, M. Saternus, Y. Kimura, K. Inaba, and R. M. Steinman. 2002. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196: 1091-1097.
33. Lu, L., C. A. Bonham, X. Liang, Z. Chen, W. Li, L. Wang, S. C. Watkins, M. A. Nalesnik, M. S. Schlissel, A. J. Demestris, et al. 2001. Liver-derived DEC205+B220+CD19-dendritic cells regulate T cell responses. J. Immunol. 166: 7042-7052.
34. Kronin, V., D. Vremec, K. Winkel, B. J. Classon, R. G. Miller, T. W. Mak, K. Shortman, and G. Süss. 1997. Are CD8+ dendritic cells (DC) veto cells? The role of CD8 on DC in DC development and in the regulation of CD4 and CD8 T cell responses. Int. Immunol. 9: 1061-1064.
35. Hofmeyer, K. A., A. Ray, and X. Zang. 2008. The contrasting role of B7-H3. Proc. Natl. Acad. Sci. USA 105: 10277-10278.
36. Prasad, D. V., T. Nguyen, Z. Li, Y. Yang, J. Duong, Y. Wang, and C. Dong. 2004. Murine B7-H3 is a negative regulator of T cells. J. Immunol. 173: 2500-2506.
37. Selenko-Gebauer, N., O. Majdic, A. Szekeres, G. Höfler, E. Guthann, U. Korthäuer, G. Zlabinger, P. Steinberger, W. F. Pickl, H. Stockinger, et al. 2003. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 170: 3637-3644.
38. Suh, W. K., B. U. Gajewska, H. Okada, M. A. Gronski, E. M. Bertram, W. Dawicki, G. S. Duncan, J. Bukczynski, S. Plyte, A. Elia, et al. 2003. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat. Immunol. 4: 899-906.
39. Karakhanova, S., T. Bedke, A. H. Enk, and K. Mahnke. 2011. IL-27 renders DC immunosuppressive by induction of B7-H1. J. Leukoc. Biol. 89: 837-845.
40. Fujimura, T., S. Ring, V. Umansky, K. Mahnke, and A. H. Enk. 2012. Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas. J. Invest. Dermatol. 132: 1239-1246.
41. Guo, M., S.Gong, S.Maric, Z. Misulovin, M. Pack,K.Mahnke, M.C. Nussenzweig, and R. M. Steinman. 2000. A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells. Hum. Immunol. 61: 729-738.